Setting the standard for cell and gene therapy manufacturing success
Cell therapy manufacturing and gene therapy manufacturing pose distinct challenges. We’ve helped dozens of advanced therapy innovators conquer them—building the largest advanced therapy manufacturing footprint in the world, while streamlining the inherent complexity to speed product to market without sacrificing quality or safety.
FACILITY BUILDS
TOTAL SPEND
PARTNERS
FIRST-EVER
FDA, EMA APPROVED THERAPIES INDUSTRIALIZED
Harness our pioneering expertise at every critical juncture
Precision for Medicine’s cell and gene therapy capabilities expanded with the acquisition of Project Farma to offer market leading expertise and practices that address the entire manufacturing lifecycle—from technical operations strategy to manufacturing execution—honed through work with leading advanced therapy companies, startups, academics, and investment firms.
Technical Operations Strategy
The complexity of both gene and cell therapy manufacturing often leads to bottlenecks that derail timelines. We provide strategic insights born from our pioneering experience in manufacturing execution to ensure success.
- Due diligence, pipeline evaluation, and mobilization
- Make-vs-buy business case analysis and execution
- Business infrastructure startup and support
- GMP infrastructure startup and support
- Program management
Manufacturing Execution
Successful gene and cell therapy manufacturing demands a range of highly specialized expertise, spanning areas from complex facility builds to stringent engineering requirements. We deliver on every front.
- Capital projects, facility builds, and tech transfers
- Quality, regulatory, and compliance
- Engineering and automation
- Validation
- Reliability, maintenance, and asset management
Harness our pioneering expertise at every critical juncture
Precision for Medicine’s cell and gene therapy capabilities expanded with the acquisition of Project Farma to offer market leading expertise and practices that address the entire manufacturing lifecycle—from technical operations strategy to manufacturing execution—honed through work with leading advanced therapy companies, startups, academics, and investment firms.
Technical Operations Strategy
The complexity of both gene and cell therapy manufacturing often leads to bottlenecks that derail timelines. We provide strategic insights born from our pioneering experience in manufacturing execution to ensure success.
- Due diligence, pipeline evaluation, and mobilization
- Make-vs-buy business case analysis and execution
- Business infrastructure startup and support
- GMP infrastructure startup and support
- Program management
Manufacturing Execution
Successful gene and cell therapy manufacturing demands a range of highly specialized expertise, spanning areas from complex facility builds to stringent engineering requirements. We deliver on every front.
- Capital projects, facility builds, and tech transfers
- Quality, regulatory, and compliance
- Engineering and automation
- Validation
- Reliability, maintenance, and asset management